Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ostial Corporation is a medical device company that developed the Flash Ostial System, a specialized dual-balloon angioplasty catheter. The system is designed to optimize the treatment of aorto-ostial lesions by ensuring precise stent positioning and complete circumferential coverage of the vessel opening. By addressing the technical difficulties associated with stenting at the ostium of coronary and renal arteries, the technology aims to reduce complications and improve clinical outcomes in interventional cardiology. The company was acquired by Merit Medical Systems in 2016 and its products are now part of Merit's interventional portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ostial.